Nouf Aloudah

Dr. Nouf Aloudah

orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 May 2018 in BMJ Open
Verified
Journal Article
Open access
PDF file
GAGhadah Assiri
Ghadah Assiri
NSNada Atef Shebl
Nada Atef Shebl
MMMansour Adam Mahmoud
Mansour Adam Mahmoud
NANouf Aloudah
Nouf Aloudah
EGElizabeth Grant
Elizabeth Grant
ASAziz Sheikh
Aziz Sheikh
Objective To investigate the epidemiology of medication errors and error-related adverse events in adults in primary care, ambulatory care and patients’ homes. Design Systematic review. Data source Six international databases were searched for publications between 1 January 2006 and 31 December 2015. Data extraction and analysis Two researchers independently extracted data from eligible studies and assessed the quality of these using established instruments. Synthesis of data was informed by an appreciation of the medicines’ management process and the conceptual framework from the International Classification for Patient Safety. Results 60 studies met the inclusion criteria, of which 53 studies focused on medication errors, 3 on error-related adverse events and 4 on risk factors only. The prevalence of prescribing errors was reported in 46 studies: prevalence estimates ranged widely from 2% to 94%. Inappropriate prescribing was the most common type of error reported. Only one study reported the prevalence of monitoring errors, finding that incomplete therapeutic/safety laboratory-test monitoring occurred in 73% of patients. The incidence of preventable adverse drug events (ADEs) was estimated as 15/1000 person-years, the prevalence of drug–drug interaction-related adverse drug reactions as 7% and the prevalence of preventable ADE as 0.4%. A number of patient, healthcare professional and medication-related risk factors were identified, including the number of medications used by the patient, increased patient age, the number of comorbidities, use of anticoagulants, cases where more than one physician was involved in patients’ care and care being provided by family physicians/general practitioners. Conclusion A very wide variation in the medication error and error-related adverse events rates is reported in the studies, this reflecting heterogeneity in the populations studied, study designs employed and outcomes evaluated. This review has identified important limitations and discrepancies in the methodologies used and gaps in the literature on the epidemiology and outcomes of medication errors in community settings.

11 December 2018 in PLOS ONE
Verified
Journal Article
Open access
PDF file
NANouf Aloudah
Nouf Aloudah
NSNeil W Scott
Neil W Scott
HAHisham S Aljadhey
Hisham S Aljadhey
VAVera Araujo-Soares
Vera Araujo-Soares
KAKhalid Al-Rubeaan
Khalid Al-Rubeaan
MWMargaret C Watson
Margaret C Watson
Oral hypoglycemic agents (OHAs) are highly effective in managing Type 2 diabetes if taken appropriately. This study assessed adherence to OHAs among patients with Type 2 diabetes and explored factors associated with adherence behaviour. Mixed methods were used comprising a cross-sectional study using the Arabic version of the Morisky Medication Adherence Scale followed by semi-structured interviews using the Theoretical Domain Framework to explore key determinants of adherence. The cross-sectional study included 395 patients of whom 40% achieved a high level of OHA adherence. Lower adherence was associated with younger age (Odds Ratio (OR) 1.084; 95% CI 1.056 to 1.112), higher numbers of non-OHAs (OR 0.848; 95% CI 0.728 to 0.986) and higher HbA1c levels (OR 0.808; 95% CI 0.691 to 0.943). Semi structured interviews based on the Theoretical Domain Framework were completed with 20 patients and identified a wide range of factors potentially associated with OHA adherence, particularly behavioural related factors (e.g. scheduling medication intake, ability to develop a habitual behaviour), social influences (e.g. acting as a role model, the effect of family support), and gaps in knowledge about diabetes and its management with OHAs. This unique mixed-methods study has highlighted possible reasons for the low levels of OHA adherence in this patient population. Whilst the theoretically-derived determinants of behaviour illustrate the complexities associated with OHA adherence, they also provide a robust underpinning for future intervention(s) development to improve adherence and maximise patient health outcomes.

1 August 2018 in Clinical Interventions in Aging
Verified
Journal Article
Open access
PDF file
MAMaha Meshal AlRasheed
Maha Meshal AlRasheed
TATariq M Alhawassi
Tariq M Alhawassi
AAAlanoud Alanazi
Alanoud Alanazi
NANouf Aloudah
Nouf Aloudah
FKFowad Khurshid
Fowad Khurshid
MAMohammed Alsultan
Mohammed Alsultan

Purpose:
This study aimed to explore the physician’s knowledge and identify the perceived barriers that prevent family medicine physicians from engaging in deprescribing among older patients. Methods: This qualitative study was designed and conducted using an interpretive theoretical approach. Purposive sampling was undertaken, whereby family medicine physicians of King Saud University Medical City (KSUMC), Riyadh, Saudi Arabia, were invited to participate in the study. The topic guidelines were designed to give the physicians the freedom to express their views on exploring their knowledge about deprescribing and to identify the perceived barriers and enablers that prevent them from engaging in the practice in older patients. The focus group discussions were conducted in English, audio-taped with permission, and transcribed verbatim. Each transcript was independently reviewed and coded separately to explore the themes and sub-themes. Results: A total of 15 physicians participated in three focus group discussions. Their thematic content analysis identified 24 factors that facilitated or hindered deprescribing. The facilitators included cost-effectiveness and time effectiveness, side effects avoidance, clinical pharmacist’s role, need for system(s) to help in applying deprescribing, and patient counseling/education. Similarly, barriers included lack of knowing the deprescribing term and process, patient comorbidities, risk/fear of conflict between physicians and clinical pharmacists, lack of documentation and communication, lack of time or crowded clinics, and patient resistance/acceptance. Conclusion: The study identified several factors affecting family medicine physician’s deprescribing behavior. The use of theoretical underpinning design helped to provide a comprehensive range of factors that can be directed when defining targets for intervention(s).

4 March 2011 in Biomedical Chromatography
Verified
Journal Article
Closed access
PDF file
MRMahasen A. Radwan
Mahasen A. Radwan
GBGhada A. Bawazeer
Ghada A. Bawazeer
NANouf Aloudah
Nouf Aloudah
BABushra AlQuadeib
Bushra AlQuadeib
HAHassan Y. Y. ABOUL-ENEIN
Hassan Y. Y. ABOUL-ENEIN

24 June 2022 in Exploratory Research in Clinical and Social Pharmacy
Verified
Journal Article
Open access
NANouf Aloudah
Nouf Aloudah
Qualitative studies are a valuable approach to exploratory research. Frequently, researchers are required to collect data in languages other than English, which requires a translation process for the results to be communicated to a wider audience. However, language-embedded meaning can be lost in the translation process, and there is no consensus on the optimum timing of translation during the analysis process. Thus, the aim of this paper was to review how researchers conduct qualitative research with Arabic-speaking participants and the timing of data translation.

1 February 2020 in Research in Social and Administrative Pharmacy
Verified
Journal Article
Closed access
HAHADI ALMANSOUR
HADI ALMANSOUR
AMAlemayehu B. Mekonnen
Alemayehu B. Mekonnen
NANouf Aloudah
Nouf Aloudah
TATariq M. Alhawassi
Tariq M. Alhawassi
KNKevin Mc Namara
Kevin Mc Namara
BSBandana Saini
Bandana Saini